Global Peritoneal Dialysis Market is expected to grow at a CAGR of 7.5% during the forecast period 2019-2026
A new research report published by Fior Markets with the title Peritoneal Dialysis Market by Treatment Type (Continuous Ambulatory Peritoneal Dialysis (CAPD), Automated Peritoneal Dialysis (APD)), Product Type, End User Region Global Industry Analysis, Market Product Type, Share, Growth, Trends, and Forecast 2019 to 2026.
As per the report published by Fior Markets, the global peritoneal dialysis market is expected to grow from USD 3.46 Million in 2018 to USD 6.18 Million by 2026 at a CAGR of 7.5% during the forecast period 2019-2026. North America is dominating the market. This dominance is due to better healthcare infrastructure and high expenditure on healthcare. Rising awareness and high accessibility to the products and services in these regions is another important growth factor.
DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/399157/request-sample
Leading companies in the industry include Baxter International Inc., Cook Inc., Fresenius Medical Care AG & Co. KGaA, Medionics International, Inc., Medtronic Plc., Newsol Technologies Inc., Poly Medicure Limited, Renax Biomedical Tech. Co., Ltd., Terumo Corp., and Utah Medical Products, Inc., and among others. In order to their enhance market position, the key players are now focusing on adopting the strategies such as product innovations, mergers & acquisitions, recent developments, joint venture, collaborations, and partnership. For instance, in 2018, Fresenius Medical Care acquired a 70% share of Guangzhou KangNiDaiSi Medical Investment Co., Ltd, which focuses on dialysis and related chronic disease services. Also, Fresenius Medical Care acquired 55% stakes in Henan Aishen Hospital Management Co. Ltd and Aishen Beijing Hospital Management Co., Ltd. as well as 60% share of Daqing Kangda Dialysis Center Co., Ltd. The company continues to expand its dialysis care network through the acquisition of further dialysis centers and renal hospitals in China. These expansion will help the Fresenius Medical to provide world-leading chronic disease management system and high-quality dialysis treatment services.
The treatment type segment is classified into Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD). The Continuous Ambulatory Peritoneal Dialysis (CAPD) segment is dominating the market with the highest share of 59.90% in 2018 due to low cost, portability, and freedom from machines. Continuous Ambulatory Peritoneal Dialysis (CAPD) cleans the body and helps to control the water and replaces the work of the diseased kidneys. CAPD is the most portable type of dialysis that use manual bags containing peritoneal dialysis fluid. CAPD is done every day, via peritoneal cavity, with bag changes four times a day. CAPD can usually be learnt easily and does not require needles. The product type segment is divided into segments such as peritoneal dialysis solution, device, peritoneal dialysis set, catheter and others. The peritoneal dialysis solution segment is dominating the market and valued around USD 1.35 Million. Peritoneal dialysis solution is important feature in every PD procedure as solutions are required for the exchange of fluid when the kidney is not functioning effectively. It the dialysis process that includes the cleansing of blood along with the elimination of extra fluids by using the peritoneal membrane i.e. the body’s natural filter. During peritoneal dialysis, a mixture of dextrose (sugar), salt, and other minerals dissolved in water, called dialysis solution, is placed in a person’s abdominal cavity through a catheter.
End user segment includes home-based dialysis and dialysis center & hospital based dialysis. The dialysis center & hospital based dialysis segment is dominating the market with the highest share of 61.30% in 2018. Hemodialysis can be done in a hospital, in a dialysis center that is not a part of a hospital or home. It depends on the patient’s condition and doctor’s advice. In a dialysis center, hemodialysis is usually done 3 times per week for about 4 hours at a time. People who choose to do hemodialysis at home may do dialysis treatment more frequently, 4-7 times per week for shorter hours each time.
Growing number of ESRD patients is one of the driving force. Also, increase in cases of diabetes & hypertension is another factor fuelling the growth of the market. But lack of demand in underdeveloped countries is restricting the growth of peritoneal dialysis market. However, growing demand for home peritoneal dialysis treatment and better opportunities in the emerging markets are the two factors which may spur the growth of the market in forthcoming years.
Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on firstname.lastname@example.org or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.
- CDN Newswire